Experience

Pharmaron

• China
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Vice President Biologics Services, Europe

  • May 2021 - Present

  Leads the biologics services business for Pharmaron in Europe. Leads the biologics services business for Pharmaron in Europe.



AbbVie

• United States
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Associate Vice President CMC Development Operations and Brazikumab Transition Lead

  • May 2020 - May 2021

  Led the successful transition of brazikumab to AstraZeneca and managed the divestment of the AbbVie Liverpool site to Pharmaron Led the successful transition of brazikumab to AstraZeneca and managed the divestment of the AbbVie Liverpool site to Pharmaron



Allergan

• Pharmaceutical Manufacturing
• 700 & Above Employee

• Hold Separate Manager, Brazikumab

  • Jan 2020 - May 2020

  Led the global development of Brazikumab, the Allergan R&D asset required to be divested by the anti-trust regulators conditional to the acquisition of Allergan by AbbVie.

• Associate Vice President CMC Development Operations

  • Apr 2018 - Jan 2020

  Responsible for Biologics clinical manufacturing strategy, external partnering and enabling technology collaborationsGlobal Core Team Lead for Brazikumab, in late stage clinical development for IBD

• Associate Vice President, Biologics R&D, Strategic Partnering

  • Jan 2017 - Mar 2018

  - Responsible for strategic partnering to support Biologics R&D activities- Product Development Core Team Lead for late stage biologic asset

• Executive Director Strategic Partnerships, Biologics R&D

  • Mar 2016 - Feb 2017

  Responsible for Strategic Partnering for Biologics R&D programs including both outsourcing and product and technology in-licensing



Actavis (now Allergan)

• Pharmaceutical Manufacturing
• 700 & Above Employee

• Chief Operating Officer

  • Mar 2014 - Feb 2016

  Leads BIologics R&D Operations, including:- Target candidate selection and biologics R&D strategy- Global biologic product development, manufacturing and testing functions- Biologics capital investment strategy and delivery- Liverpool's engineering and facilities capability- Third party and supply chain management Leads BIologics R&D Operations, including:- Target candidate selection and biologics R&D strategy- Global biologic product development, manufacturing and testing functions- Biologics capital investment strategy and delivery- Liverpool's engineering and facilities capability- Third party and supply chain management



Eden Biodesign Ltd

• Chief Operating Officer

  • Jan 2009 - Feb 2014

  Responsible for business operations, including:- Process Development- cGMP Manufacture- Analytical Development and QC- Client Project Management- Engineering and Validation

• VP Development & Manufacturing

  • Nov 2007 - Dec 2008

  Responsible for all development and manufacturing operations, including:- Analytical Development- Process Development- cGMP ManufactureAcross a broad range of biopharmaceutical product technologies

• Business Development Director

  • Jul 2004 - Nov 2007

  Directed Eden Biodesign's global business development activities, including order winning, marketing, public relations and project management. Successfully negotiated £34 million National Biomanufacturing Centre contract with UK government and established Eden Biodesign as a leading European Contract Manufacturing Organisation.



Eden Biopharm

• Co-founder and senior consultant

  • Sep 2000 - Jul 2004

  Co-founder of Eden Biopharm. Provided consultancy in biopharmaceutical development to over 30 UK and international clients in analytical development, cGMP manufacture and regulatory affairs. Co-founder of Eden Biopharm. Provided consultancy in biopharmaceutical development to over 30 UK and international clients in analytical development, cGMP manufacture and regulatory affairs.



Celltech Medeva

• Analytical Development Manager

  • Jul 1996 - Sep 2000



Wellcome Centre for Cell Matrix Research

• Post Doc

  • Jan 1995 - Aug 1996